Research of relations among sleep disorders, obstructive sleep apnoea, hypertension onset and hypertensive treatment – current or long-term trend?

1. Cappuccio FP, Cooper D, D´Elia L et al. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011; 32(12): 1484–1492.

2. Gottlieb DJ, Redline S, Nieto FJ et al. Association of unusual sleep duration with hypertension: the Sleep Hearth Health Study. Sleep 2006; 29(8): 1009–1014.

3. Gangwisch JE, Heymsfield SB, Boden-Albala B et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 2006; 47(5): 833–839.

4. Knutson KL, Turek FW. The U-shaped association between sleep and health: the 2 peaks do not mean the same thing. Sleep 2006; 29(7): 878–879.

5. Lévy P, Tamisier R, Minville C et al. Sleep apnoea syndrome in 2011: current concepts and future directions. Eur Respir Rev 2011; 20(121): 134–146.

6. Nevšímalová S, Šonka K. Poruchy spánku a bdění. 2nd ed. Galén: Praha 2007. ISBN: 978–80–7262–500–0.

7. Parati G, Lombardi C, Hedner J et al. Recommendation for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 2013; 41(3): 523–538.

8. International classification of sleep disorders (ICSD-2). 2nd diagnostic and coding manual. American Academy of Sleep Medicine: Westchester 2005. ISBN 978–0965722025.

9. Šonka, K, Slonková, J. Spánková apnoe dospělého věku. Česk Slov Neurol N 2008; 71/104(6): 643–656.

10. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34(28): 2159–219.

11. Calhoun DA, Harding SM. Sleep and hypertension. Chest 2010; 138(2): 434–443.

12. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectation from prospective epidemiological studies. BMJ 2009; 338: b1665.

13. Filipovský J, WIdimský jr. J, Ceral J et al. Diagnostické a léčebné postupy u arteriální hypertenze-verse 2012. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2012; 58(10): 785–801.

14. Peppard PE, Young T, Palta M et al. Prospective study of the association between sleep- disordered breathing and hypertension. N Engl J Med 2000; 342(19): 1378–84.

15. O´Brien E, Parati G, Stergiou G et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31(9): 1731–1768. Erratum inJ Hypertens. 2013; 31(12): 2467.

16. Somers VK, White DP, Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008; 118(10): 1080–111.

17. Baquet JP, Barone-Rochette G, Pépin JL. Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertens 2009; 23(7): 431–443.

18. Logan AG, Perlikowski SM, Mente A et al. High prevalence of unrecognised sleep apnoea in drug resistant hypertension. J Hypertens 2001; 19(12): 2271–2277.

19. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000; 320(7233): 479–482.

20. Young T, Palta M, Dempsey J et al. The occurence of sleep disordered breathing among middle aged adults. N Engl J Med 1993; 328(17): 1230–1235.

21. Wang Y, Li C, Feng L et al. Prevalence of hypertension and circadian blood pressure variations in patients with obstructive sleep apnoea-hypopnoea syndrome. J Int Med Res 2014; 42(3): 773–780.

22. Olivarez SA, Ferres M, Antony K et al. Obstructive sleep apnea screening in pregnancy, perinatal outcomes and impact of maternal obezity. Am J Perinatol 2011; 28(8): 651–658.

23. Parati G, Lombardi C, Hedner J et al. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens 2012; 30(4): 633–646.

24. Yuchiri Y, Bakris G. Recognition and management of masked hypertension: A review and novel approach. J Am Soc Hypertens 2013; 7(3): 244–252.

25. Pickering TG, Eguchi K, Kario K. Masked hypertension: A review. Hypertens Res 2007; 30(6): 479–488.

26. Fagard RH, Cormelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007; 25(11): 2193–2198.

27. Stergiou GS, Asayana K, Thijs L et al. International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension 2014; 63(4):675–682.

28. Hansen TW, Kikuya M, Thijs L et al. IDACO Investigators. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens 2007; 25(8): 1554–1564.

29. Angeli F, Reboldi G, Verdecchia P. Masked hypertension: Evaluation, prognosis, and treatment. Am J Hypertens 2010; 23(9): 941–948.

30. Drager L, Pedrosa RP, Diniz PM et al. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension 2011; 57(3): 549–555.

31. Baguet JP, Levy P, Rochette GP et al. Masked Hypertension in obstructive sleep apnea syndrome. J Hypertens 2008; 26(5): 885–892.

32. Sova M, Sovová E, Hobzová M et al. Prevalence of masked and nocturnal hypertension in patients with obstructive sleep apnea syndrome. Cor et Vasa 2014; 56(2): e153-e157.

33. Issa FG. Effect of clonidine in obstructive sleep apnea. Am Rev Respir Dis 1992; 145(2 Pt 1): 435–439.

34. Kraiczi H, Hedner J, Peker Y et al. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000; 161(5): 1423–1428.

35. Heitmann J, Greulich T, Reinke C et al. Comparison of the effects of nebivolol and valsartan on BP reduction and sleep apnoea activity in patients with Essentials hypertension and OSA. Curr Med Res Opin 2010; 26(8): 1925–1932.

36. Ziegler MG, Milic M, Sun P. Antihypertensive therapy for patients with obstructive sleep apnea. Curr Opin Nephrol Hypertens 2011; 20(1): 50–55.

37. Marin JM, Agusti A, Villar I et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 2012; 307(20): 2169–2176.

38. Gaddam K, Pimenta E, Thomas SJ et al. Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 2009; 24(8): 532–537.

39. Nerbass FB, Pedrosa RP, Genta PR et al. Calcium channel blockers are independenty associated with short slep duration in hypertensive patients with obstructive sleep apnea. J Hypertens 2011; 29(6): 1236–1241.

40. Zou D, Grote L, Eder DN et al. A double blind, crossover study of doxazocin and enalapril on peripheral vascular tone and nocturnal blood pressure in sleep apnea pacients. Sleep Med 2010; 11(3): 325–328.

41. Philips B, Shafazand S. CPAP and hypertension in nonsleepy patients. J Clin Sleep Med 2013; 9(2): 181–182.

42. Barbé F, Durán-Cantolla J, Sanchez de la Torre M et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patiens with obstructive sleep apnea: a randomized controlled trial. JAMA 2012; 307(20): 2161–2168.

43. Bottini P, Taranto-Montemurro L, Novali M et al. Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study. Respir Med 2012; 106(9): 1329–1234.

44. Bazzano LA, Khan Z, Reynolds K et al. Effect of nocturnal nasal continous positive airway pressure on blood pressure in obstructive sleep apnoea. Hypertension 2007; 50(2): 417–423.

45. Alajmi M, Mulgrew AT, Fox J et al. Impact of continous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnoea: a meta analysis of randomized controlled trials. Lung 2000; 185(2): 67–72.

46. Mo L, He QY. Effect of long term continuous positive airway pressure ventilation on blood pressure in patients with obstructive sleep apnea hypopnea syndrome: a meta analysis of clinical trials. Zhonghua Yi Za Zhi 2007; 87(17): 1177–1180.

47. Haentjens P, Van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta analysis of placebo controlled randomized trials. Arch Intern Med 2007; 167(8): 757–764.

48. Montesi S, Edwards BA, Malhota A et al. The effect of continous positive airway pressure treatment on blood pressure: a systematic review and meta analysis of randomized cotrolled trial. J Clin Sleep Med 2012; 8(5): 587–596.

49. Schein AS, Kerkhoff AC, Coronel CC et al. Continuous positive airway pressure reduces blood pressure in patients with obstructive sleep apnea; a systematic review and meta-analysis with 1000 patients. J Hypertens 2014; 32(9):1762–1773.

50. Sova M, Sovová E, Hobzová M et al. The influence of continuous positive airway pressure therapy on prevalence of masked hypertension in patients with obstructive sleep apnea. Sleep Medicine 2013; 14(Suppl 1): e274. Dostupné z DOI: <http://doi: 10.5507/bp.2014.063>.

51. Bakker JP, Edwards BA, Gautam SP et al. Blood pressure improvement with continuous positive airway pressure is independent of obstructive sleep apnea severity. J Clin Sleep Med 2014; 10(4): 365–369.

52. Aggarwal S, Nadeem R, Loomba RS et al. The effects of continuous positive airways pressure therapy on cardiovascular end points in patients with sleep-disordered breathing and heart failure: a meta-analysis of randomized controlled trials. Clin Cardiol 2014; 37(1): 57–65.

53. Shantha GP, Pancholy SB. Effect of renal sympathetic denervation on apnea-hypopnea index in patients with obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath 2014: Epub ahead of print. Accession Number 12014034133.

54. Iftikhar IH, Hays ER, Iverson MA et al. Effect of oral appliances on blood pressure in obstructive sleep apnea: a systematic review and meta-analysis. J Clin Sleep Med. 2013; 9(2): 165–174.

55. Gottlieb DJ, Punjabi NM, Mehra R et al. CPAP versus oxygen in obstructive sleep apnea. N Engl J Med 2014; 370(24): 2276–2285.